We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$745M 5.25%
3,197,635
+776,361
+32% +$205M
AAPL icon
2
Apple
AAPL
$4.81T
$639M 4.5%
4,626,608
+1,437,985
+45% +$226M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.24T
$397M 2.79%
4,145,274
+591,134
+17% +$65.6M
MRK icon
4
Merck
MRK
$312B
$300M 2.11%
3,478,558
-3,480
-0.1% -$311K
REGN icon
5
Regeneron Pharmaceuticals
REGN
$70.5B
$277M 1.95%
402,521
+29,728
+8% +$18.7M
UNH icon
6
UnitedHealth
UNH
$396B
$244M 1.72%
483,918
+94,462
+24% +$49.7M
DHR icon
7
Danaher
DHR
$127B
$229M 1.61%
999,704
-2,910
-0.3% -$712K
AMGN icon
8
Amgen
AMGN
$198B
$218M 1.53%
965,925
+30,010
+3% +$7.27M
TMO icon
9
Thermo Fisher Scientific
TMO
$195B
$217M 1.53%
427,864
+23,598
+6% +$13.2M
PG icon
10
Procter & Gamble
PG
$345B
$200M 1.41%
1,581,109
+170,701
+12% +$24.2M
TSLA icon
11
Tesla
TSLA
$1.42T
$190M 1.34%
717,085
+298,006
+71% +$83.2M
LLY icon
12
Eli Lilly
LLY
$1.02T
$178M 1.25%
548,963
+68,254
+14% +$21.6M
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.22T
$145M 1.02%
1,504,828
+580,968
+63% +$64.9M
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$122B
$140M 0.99%
484,539
+16,656
+4% +$4.79M
AMZN icon
15
Amazon
AMZN
$2.66T
$134M 0.94%
1,181,933
+221,613
+23% +$28M
V icon
16
Visa
V
$677B
$132M 0.93%
742,041
+156,446
+27% +$31.8M
GILD icon
17
Gilead Sciences
GILD
$165B
$124M 0.87%
2,010,904
-19,355
-1% -$1.22M
ABT icon
18
Abbott
ABT
$174B
$110M 0.78%
1,136,939
+293,977
+35% +$31.3M
BAC icon
19
Bank of America
BAC
$430B
$108M 0.76%
3,577,933
+635,601
+22% +$21.2M
DIS icon
20
Walt Disney
DIS
$167B
$108M 0.76%
1,144,797
+146,197
+15% +$15.6M
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
$101M 0.71%
740,028
-38,017
-5% -$6.19M
MA icon
22
Mastercard
MA
$484B
$99.9M 0.7%
351,333
+171,539
+95% +$56.9M
DAR icon
23
Darling Ingredients
DAR
$10.2B
$92.6M 0.65%
1,399,907
+762,026
+119% +$53.1M
CSCO icon
24
Cisco
CSCO
$442B
$92.2M 0.65%
2,305,604
+839,559
+57% +$37.2M
ADSK icon
25
Autodesk
ADSK
$46B
$88.3M 0.62%
472,682
+25,475
+6% +$5.15M

Similar funds

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.